Prospects for CBD in Brazil – like so much else in the world’s fifth largest country – depend hugely on the outcome of the forthcoming presidential election, in which the far right-wing candidate Jair Bolsonaro has emerged as a very strong favourite.

As a hardcore conservative, Bolsonaro is unlikely to look favourably on CBD. And, indeed, he has tweeted that he has “always been against drugs and abortion”.

Bolsonaro’s likely victory may not be good news for those few projects hoping to establish CBD in Brazil, and may cause those foreign firms already investing in the country to think again.

In Brazil at present, CBD remains a tightly controlled medical product only really available to the rich. And there are already major bureaucratic obstacles to its market development.

Read full article
I'm already a subscriber
Author default picture


This article was written by one of CannIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual cannabis and cannabinoid markets. For a full list, please see our Who We Are page.

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization